IPS e.max presentations 95% dental survival price

SCHAAN, Liechtenstein: The Ivoclar Staff, a number one producer of built-in answers for high quality dental care, has printed the fourth quantity of the IPS e.max Clinical Document. Providing a concise evaluation of the medical efficiency of the ceramic subject material circle of relatives, the record summarises greater than 20 world research and confirms documented survival charges of over 95%.

IPS e.max is among the maximum totally evaluated ceramic techniques to be had: greater than 230 million restorations had been positioned international as of December 2024, and medical knowledge in this ceramic circle of relatives spans 16 years. The portfolio contains lithium disilicate (IPS e.max Press and IPS e.max CAD), high-strength zirconia (IPS e.max ZirCAD) and a fluorapatite layering ceramic (IPS e.max Ceram). Whether or not for single-tooth restorations, bridges or implant-supported answers, the fabrics allow aesthetic, long-lasting and customized remedy approaches in each analogue and virtual workflows.

Scientific proof builds self assurance

The record paperwork particularly excessive survival charges:

96.5% for IPS e.max Press over 16.9 years;
97.2% for IPS e.max CAD over ten years; and
99.0% for IPS e.max ZirCAD over 5 years.

This tough proof permits for predictable remedy making plans, reduces the will for retreatment, and fosters agree with between dental practices, sufferers and dental laboratories. The record supplies an evidence-based basis for knowledgeable decision-making and is meant to improve practices and laboratories in deciding on fabrics with clinically confirmed high quality and long-term reliability for his or her sufferers.

Quantity 4 of the IPS e.max Clinical Document can also be bought via the corporate’s web site.